Virus-specific T cells may predict immunotherapy success for a rare brain infection

Progressive multifocal leukoencephalopathy (PML) is a rare but serious brain infection. It gradually destroys brain tissue ...
Indianapolis Recorder

Black history month: Honoring Black health leaders from past to present

As Black History Month continues, communities across the country are taking time to recognize the individuals whose work has ...
Technology Networks

Blood Centers’ Expanding Role in Advancing Cell and Gene Therapy

Explore how community blood centers are shaping the future of cell and gene therapies, from customized collections to ...
Informationsdienst Wissenschaft

T cells determine success of immunotherapy for brain infection PML

MHH researchers have found biomarkers that predict which patients will benefit from treatment with checkpoint inhibitors. The original paper ‘Virus-Specific T Cells and Response to Checkpoint ...
dvm360

Communicating behavior expectations

In this video, Valuska discusses how pet owners unintentionally miscommunicate their behavior expectations to their companion ...
The American Journal of Managed Care

High-Performing MID Programs Integrate Pharmacists Into Oncology Care Teams: Q&A with Osama Abdelghany, PharmD

Osama Abdelghany, PharmD, explains how medically integrated dispensing improves oncology workflows, patient access, and outcomes through EMR-driven care. Medically integrated dispensing (MID) has the ...